Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
24
VNDA Quote, Financials, Valuation and Earnings
Last price:
$4.86
Seasonality move
:
-4.37%
Day range:
$4.77 - $4.89
52-week range:
$3.46 - $6.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.46x
P/B ratio:
0.52x
Volume:
510.4K
Avg. volume:
616.7K
1-year change:
14.32%
Market cap:
$279.3M
Revenue:
$192.6M
EPS (TTM):
-$0.28
Vanda Pharmaceuticals SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
VNDA
Vanda Pharmaceuticals
|
05/09/2024 | 10-Q | 10-Q filing on 05/09/2024 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/09/2023 | 10-Q | 10-Q filing on 11/09/2023 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/28/2023 | 10-Q | 10-Q filing on 07/28/2023 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/03/2023 | 10-Q | 10-Q filing on 05/03/2023 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/03/2022 | 10-Q | 10-Q filing on 11/03/2022 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/04/2022 | 10-Q | 10-Q filing on 08/04/2022 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/06/2022 | 10-Q | 10-Q filing on 05/06/2022 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/04/2021 | 10-Q | 10-Q filing on 11/04/2021 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/06/2021 | 10-Q | 10-Q filing on 05/06/2021 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
10/29/2020 | 10-Q | 10-Q filing on 10/29/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/06/2020 | 10-Q | 10-Q filing on 08/06/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/07/2020 | 10-Q | 10-Q filing on 05/07/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/26/2020 | 10-K | 10-K filing on 02/26/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/07/2019 | 10-Q | 10-Q filing on 11/07/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/01/2019 | 10-Q | 10-Q filing on 08/01/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/03/2019 | 10-Q | 10-Q filing on 05/03/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/19/2019 | 10-K | 10-K filing on 02/19/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/07/2018 | 10-Q | 10-Q filing on 11/07/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/02/2018 | 10-Q | 10-Q filing on 08/02/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/02/2018 | 10-Q | 10-Q filing on 05/02/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/15/2018 | 10-K | 10-K filing on 02/15/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/08/2017 | 10-Q | 10-Q filing on 11/08/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/03/2017 | 10-Q | 10-Q filing on 08/03/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/03/2017 | 10-Q | 10-Q filing on 05/03/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/17/2017 | 10-K | 10-K filing on 02/17/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/03/2016 | 10-Q | 10-Q filing on 11/03/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/28/2016 | 10-Q | 10-Q filing on 07/28/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/05/2016 | 10-Q | 10-Q filing on 05/05/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/12/2016 | 10-K | 10-K filing on 02/12/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/04/2015 | 10-Q | 10-Q filing on 11/04/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/31/2015 | 10-Q | 10-Q filing on 07/31/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
06/10/2015 | 10-K | 10-K filing on 06/10/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/07/2015 | 10-Q | 10-Q filing on 05/07/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
03/13/2015 | 10-K | 10-K filing on 03/13/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
